Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.

加强型 COVID-19 mRNA 疫苗接种可改善老年人受损的 B 细胞反应,但不能改善 T 细胞反应

阅读:5
作者:Kometani Kohei, Yorimitsu Takaaki, Jo Norihide, Yamaguchi Erina, Kikuchi Osamu, Fukahori Masaru, Sawada Takeshi, Tsujimoto Yoshitaka, Sunami Ayana, Li Mengqian, Ito Takeshi, Pretemer Yann, Gao Yuxian, Hidaka Yu, Yamamoto Masaki, Kaku Natsuko, Nakagama Yu, Kido Yasutoshi, Grifoni Alba, Sette Alessandro, Nagao Miki, Morita Satoshi, Nakajima Takako E, Muto Manabu, Hamazaki Yoko
Age-associated differences in the effect of repetitive vaccination, particularly on memory T-cell and B-cell responses, remain unclear. While older adults (aged ≥65 years) exhibited enhanced IgG responses following COVID-19 mRNA booster vaccination, they produced fewer spike-specific circulating follicular helper T cells-1 than younger adults. Similarly, the cytotoxic CD8(+) T-cell response remained diminished with reduced PD-1 expression even after booster vaccination compared with that in younger adults, suggesting impaired memory T-cell activation in older adults. In contrast, although B-cell responses in older adults were weaker than those in younger adults in the primary response, the responses were significantly enhanced upon booster vaccination, reaching levels comparable with that observed in younger adults. Therefore, while booster vaccination ameliorates impaired humoral immunity in older adults by efficiently stimulating memory B-cell responses, it may less effectively enhance T-cell-mediated cellular immunity. Our study provides insights for the development of effective therapeutic and vaccine strategies for the most vulnerable older population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。